These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24043903)

  • 1. Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.
    Lee DJ; Taylor AW
    J Immunol; 2013 Oct; 191(8):4103-11. PubMed ID: 24043903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen.
    Lee DJ; Taylor AW
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8862-7. PubMed ID: 21989727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response.
    Lee DJ; Preble J; Lee S; Foster CS; Taylor AW
    Sci Rep; 2016 Nov; 6():37790. PubMed ID: 27886238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortin 5 receptor and ocular immunity.
    Taylor AW; Kitaichi N; Biros D
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):53-9. PubMed ID: 16914087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from experimental autoimmune uveitis promotes induction of antiuveitic inducible Tregs.
    Lee DJ; Taylor AW
    J Leukoc Biol; 2015 Jun; 97(6):1101-9. PubMed ID: 25877928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Deficiency of the Melanocortin 5 Receptor and Adenosine 2A Receptor Unexpectedly Provides Resistance to Autoimmune Disease in a CD8
    McDonald T; Muhammad F; Peters K; Lee DJ
    Front Immunol; 2021; 12():742154. PubMed ID: 34867964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1
    Muhammad F; Wang D; Montieth A; Lee S; Preble J; Foster CS; Larson TA; Ding K; Dvorak JD; Lee DJ
    Sci Rep; 2019 Nov; 9(1):16941. PubMed ID: 31729418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
    Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
    Front Immunol; 2020; 11():2071. PubMed ID: 33013877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of autoimmune uveitis by obesity occurs through the melanocortin 5 receptor.
    Muhammad FY; Peters K; Wang D; Lee DJ
    J Leukoc Biol; 2019 Oct; 106(4):879-887. PubMed ID: 31287586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
    Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
    EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
    Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
    Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
    Lee DJ; Biros DJ; Taylor AW
    Int Immunopharmacol; 2009 Aug; 9(9):1079-86. PubMed ID: 19426838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
    Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
    Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Regulatory T Cells in Spleen during Experimental Autoimmune Uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Lin X; Kijlstra A
    Ocul Immunol Inflamm; 2010 Jan; 18(1):38-43. PubMed ID: 20128648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible immune regulation following autoimmune disease in the immune-privileged eye.
    Kitaichi N; Namba K; Taylor AW
    J Leukoc Biol; 2005 Apr; 77(4):496-502. PubMed ID: 15647326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Generated by Regulatory T Cells Induces CD8
    Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
    Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.